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The  ability  of  a  eukaryotic  cell  to precisely  and  accurately  replicate  its DNA  is crucial  to  maintain  genome
stability.  Here  we describe  our current  understanding  of the  process  by  which  origins  are  licensed  for  DNA
replication  and  review  recent  work  suggesting  that fork  stalling  has  exerted  a strong  selective  pressureeywords:
CM2–7
rigin licensing
eplication origins
ormant origins
eier–Gorlin
on  the  positioning  of  licensed  origins.  In light  of this,  we  discuss  the  complex  and  disparate  phenotypes
observed  in  mouse  models  and  humans  patients  that  arise  due  to  defects  in replication  licensing  proteins.
© 2014  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/3.0/).re-RC
. Introduction
Because of the very large size of eukaryotic chromosomes, they
eed to be replicated by many hundreds or thousands of replication
orks which are initiated from replication origins spaced through-
ut the genome. The use of multiple replication origins not only
nsures timely completion of genome duplication, but also allows
ells to replicate different regions of the genome at different stages
f S phase (the ‘replication timing programme’)—this may  help cells
ssemble nascent DNA into different chromatin or transcriptional
tates. However, the use of multiple replication origins makes it
ore difﬁcult to ensure that the entire genome is precisely dupli-
ated during each S phase, with no sections left unreplicated and
o sections replicated more than once (under- and over-replication,
ig. 1). Cells resolve these challenges and preserve genome integrity
y dividing the whole process of replication initiation into two
istinct non-overlapping steps: origin ‘licensing’ which occurs in
ate mitosis and G1, and origin ‘ﬁring’ which occurs during S phase
2,9,33].
From late mitosis through G1 phase, replication origins are
icensed for use in the upcoming S-phase by loading double hex-
mers of MCM2–7 (mini chromosome maintenance) proteins onto
NA [25,28,33,63]. During S phase, two S-phase kinases Cdc7 and
DKs promote the binding of Cdc45 and the GINS complex to
ome of the MCM2–7 hexamers at licensed origins. This forms a
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568-7864/© 2014 The Authors. Published by Elsevier B.V. This is an open access article ufunctional CMG  (CDC45, MCM2–7, GINS) helicase which powers
the progression of the replication fork [41,54]. Origin ﬁring and
consequent movement of the CMG  away from the origin reverts
it back to an unlicensed state. Additionally, as active replication
forks encounter MCM2–7 hexamers at unﬁred origins, the inactive
MCM2–7 complexes are removed from the DNA. This combination
of features prevents the re-replication of chromosomal DNA.
In order to prevent DNA re-replication, it is critical that any
further origin licensing ceases at the onset of S-phase [2,9]. As a con-
sequence, if problems occur during S phase – such as the stalling
or disassembly of replication forks – the cell cannot alleviate the
problem by licensing new origins. Cells therefore license many
more origins than are normally used, with many origins remaining
‘dormant’ to provide a backup in case of problems during S phase
[11].
Here we  will discuss the recent evidence from yeast showing
that these pressures have had a major inﬂuence on the distribution
of replication origins. We will describe how activation of otherwise
dormant replication origins provides an important defence against
many potential genotoxic stresses. We  will review work on mouse
and human mutant genes that are involved in origin licensing and
discuss how these mutations might cause the observed cellular and
developmental defects.
2. Origin licensingOrigin licensing in late mitosis and G1 occurs in a series of
biochemical steps that result in the clamping of two MCM2–7 hex-
amers in an antiparallel conformation around double stranded DNA
[25,28,33,63]. This assembly is driven by three essential factors
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Fig. 1. Ensuring precise chromosome replication. A small segment of chromosomal
DNA is shown, consisting of three domains each replicated from three replication
origins. The domain is shown at different stages of the cell cycle: G1, early-, mid- and
late-S phase and G2; a whole chromosome containing the chromosomal segment is
shown in mitosis (‘M’). (A) The DNA is under-replicated as a consequence of origins in
the middle cluster failing to ﬁre. As sister chromatids are separated during anaphase,
the chromosome is likely to be broken near the unreplicated section. (B) Origins
are  correctly used and chromosomal DNA is successfully duplicated. (C) One of the
origins ﬁres for a second time in S phase. The local duplication of DNA in the vicinity
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the other fork can compensate and replicate all of the interveningf  the over-ﬁring origin represents an irreversible genetic change and might be
esolved to form a tandem duplication. Reproduced from [11].
hich together with MCM2–7 form the ‘pre-replicative complex’
pre-RC): ORC (origin recognition complex), CDC6 and CDT1. ORC
onsists of 6 subunits, ORC1 to ORC6, though in some cell types
RC6 is absent from the complex. ORC binds to origin DNA, and
hen promotes the association of CDC6, which then with the help
f CDT1 recruits two hexamers of MCM2–7 [26,27]. Once a double
examer is loaded, it remains stably associated with the DNA until
he DNA is replicated [44,70,72].
In contrast to MCM2–7, the other pre-RC components only
ssociate transiently with the DNA. Photobleaching studies of
FP-tagged ORC subunits in Chinese Hamster Ovary cells and in
aenorhabditis elegans,  show that ORC turnover on DNA typically
ccurs in a few seconds [53,70]. A similar dynamic association of
DC6 and CDT1 with DNA has also been reported [83,70]. Inter-
stingly, in both Xenopus laevis and C. elegans early embryos, the
oading of MCM2–7 onto DNA appears to promote the destabi-
ization of ORC, CDC6 and CDT1 [59,70]. This is consistent with
bservations made in the reconstituted Saccharomyces cerevisiae
ystem, where ORC and CDC6 are probably ejected from the ori-
in in a mechanism involving ATP hydrolysis [13,27,78]. Since
CM2–7 double hexamers are loaded in a considerable excess
ver the amount of ORC, it has been proposed that the destabi-
ization of the ORC, CDC6 and CDT1 complex that occurs when
rigins are licensed could provide a mechanism for distributing
eplication origins along chromosomal DNA [70]. This is consistent
ith studies showing that there is a signiﬁcant excess of MCM2–7
ouble-hexamers loaded onto DNA when compared to the amount
f ORC [11,22,24,52,81].
In every cell type examined so far, there is also a 3- to 20-
old excess of MCM2–7 double hexamers loaded onto DNA over
he number of origins that are actually used in any individual S
hase [11,39,81]. One explanation for this ‘MCM paradox’ is that
nly a fraction of licensed origins are actually used in any given
 phase, with the majority remaining dormant. The existence of
ormant replication origins is clearly revealed under conditions of
eplication stress: if replication forks stall or their progression is
mpeded, dormant origins are activated and this is important so that
he entire genome can be completely replicated (see Section 4 onr 19 (2014) 182–189 183
‘dormant origins’) [1,11,30,82]. In addition, it is possible that more
than one MCM2–7 double hexamer might be loaded at certain ori-
gins. Having several MCM2–7 double hexamers at one site could
increase the probability of the origin ﬁring, which provides various
theoretical advantages to organising S phase [42,65,85]. However,
to date no direct evidence has been reported for such a hyperload-
ing of MCM2–7 at individual origins.
3. Origin distribution
For all functional purposes, a DNA sequence gains the potential
to act as an origin by being loaded with MCM2–7 double hexam-
ers (i.e. by becoming licensed) whilst these licensed sites actually
become replication origins in a cell only when the MCM2–7 hex-
amers are transformed into an active CMG  helicase. The features
that specify metazoan replication origins have been debated for
a long while, and much still remains unclear. In S. cerevisiae, ORC
binds to an A/T-rich consensus sequence (ACS). Possession of this
consensus sequence is not sufﬁcient to predict the existence of a
functional DNA replication origin. In fact, out of the 12,000 ACS
sites identiﬁed only 400 are functional [58]. The location of the
ACS within an extended nucleosome-free region may contribute
to it becoming a functional origin [23]. There is no analogous ACS
in the distantly related yeast Schizosaccharomyces pombe,  though
the position of replication origins correlates highly with AT-rich
and poly-A DNA [84]. These features probably contribute to origin
speciﬁcation in at least two  ways: ﬁrst, S. pombe ORC shows a strong
preference for binding AT-rich DNA, and second, AT-richness may
help create nucleosome-free regions which promote origin activity
[84]. In metazoan cells, origin speciﬁcation is even less well under-
stood than in yeasts, though recent deep sequencing studies have
highlighted the possible importance of GC-rich sequence elements
[5,14,16].
What is the signiﬁcance of positioning replication origins at
particular places on chromosomal DNA? It is likely that certain
regions are unfavourable for locating replication origins, such as
within complex promoters or in the middle of highly transcribed
genes. But these provide very limited constraints on where origins
might actually be placed. If origins were placed at random sites on
the genome, this would result in some adjacent replication origins
being very far apart. There are two obvious negative consequences
of having a few widely-spaced replication origins. Firstly, this in
principle sets the minimum time for the entire genome to be repli-
cated as the time taken for the two  forks initiated from the most
widely-spaced pair of origins to traverse the gap between them.
This is likely to be an important limitation for organisms such as
early embryos which have a very short S phase. But for somatic
cells, with a much longer S phase driven by a replication timing
programme and active checkpoint responses to delay entry into
S phase, this might not pose a potential threat. A second negative
consequence of having large inter-origin gaps arises from problems
that occur if replication forks irreversibly stall, for example, after
encountering damaged or chemically modiﬁed DNA  [57]. Because
licensing only occurs before the onset of S phase, no new origins
can be licensed to rescue these stalled forks. This is potentially an
important problem for all cells.
When forks encounter barriers to their movement, such as
might be created by DNA damage or proteins tightly bound to DNA,
this can lead to an irreversible fork arrest. Some protection against
fork stalling arises from the fact that each origin initiates a pair
of bi-directional forks, so that if one of the converging forks stalls,DNA (Fig. 2A). However, if both converging forks stall (a ‘dou-
ble fork stall’), replication of the intervening DNA is compromised
(Fig. 2B). A new origin cannot be licensed between the two stalled
184 R.C. Alver et al. / DNA Repair 19 (2014) 182–189
Fig. 2. Cartoon of replication origins near the end of a chromosome. DNA is denoted as a single black line, with a telomere (chromosome end) to the left. Prior to S phase
entry,  origins are licensed by binding a double hexamer of MCM2–7 proteins (blue). As an origin ﬁres, both MCM2–7 single hexamers are converted into an active CMG
helicase (pink). (A) Forks initiate at origins 1, 3 and 4. If an active fork passively replicates an inactive origin, the MCM2–7 at the inactive origin is displaced making the origin
dormant  (origin 2) for that particular cell cycle. (B) In case of irreversible fork stalling (denoted by a red cross) otherwise dormant origins can be activated (origin 2) to ensure
complete replication of the DNA. If both of the converging forks stall (‘double fork stall’) without a dormant origin existing between them (as occurs at forks converging
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oetween origins 3 and 4), replication of the intervening DNA is compromised. If the
talls  and there is no telomere-distal origin, (‘telomeric fork stall’), then this single 
orks, because new origin licensing is prohibited once S phase has
egun in order to prevent re-replication of chromosomal segments
2,9,12,57]. It should also be noted that there is a particular problem
ith DNA at the end of a chromosome, which can only be replicated
y forks coming from the body of the chromosome. Replication can
ail at chromosome ends if a single replication fork stalls in telom-
ric or subtelomeric DNA and there is no other licensed origin distal
o the stalled fork (Fig. 2B, ‘telomeric fork stall’).
The theoretical estimations of replication origin spacing
equired to minimize ‘double fork stalls’ or ‘telomeric fork stalls’
as been compared with the actual origin positions in ﬁve different
east species [57]. The probability of a double fork stall increases
s the square of the distance between two adjacent origins, so dou-
le fork stalls are proportionately more likely to occur between
istantly spaced origins. Large inter-origin distances should there-
ore be avoided, and in all 5 yeasts examined (S. cerevisiae,  S. pombe,
luyveromyces lactis, Lachancea kluyveri and Lachancea waltii) this is
learly the case. Indeed, previous work [75] had shown that deletion
f ﬁve origins in S. cerevisiae,  creating a large inter-origin distance
f 160 kb (close to the expected value of the largest inter-origin dis-
ance if origins were randomly distributed), resulted in an increased
hromosome loss rate exactly in line with the increased probability
f double fork stalls [57]. In order to globally minimize large gapse fork heading towards the telomere (the fork move left from origin 1) irreversibly
vent can also compromise full replication of the genome. Reproduced from [57].
and the probability of double fork stalls, it is also optimal to position
replication origins at regularly spaced intervals across the genome.
Consistent with this, replication origins in all 5 yeasts showed a
signiﬁcant degree of regularity in their spacing [57]. Chromosomal
ends are in a precarious situation since there is no converging fork
that can rescue fork stalling from the most distal fork found near
the chromosome end. This fact allows the prediction that origins
should be located very close to the end of chromosomes. Indeed,
this is the case for all 16 S. cerevisiae chromosomes, with the average
origin distance from the chromosome ends being ∼50 times smaller
than the average inter-origin distance in the body of chromosomes.
Taken together, all these considerations suggest that replisome stall
events have strongly shaped the distribution of replication origins
in yeasts [57].
The probability that a double fork stall occurs somewhere in
the genome is dependent on three main factors: (i) the genome
size, (ii) the distance between licensed origins and iii) the distance
that replication forks would be expected to travel before they irre-
versibly stall. Newman et al. [57] used a range of published data
to estimate a median stall distance of ∼10 Mbp  in unstressed cells.
Interestingly, this is about the size of the genomes of the ﬁve yeasts
studied, and predicts that double fork stalls will be rare events that
occur at a frequency similar to the natural chromosome loss rate.
 Repai
B
m
m
h
s
F
q
i
s
ﬁ
r
i
o
4
i
n
i
d
e
(
3
p
e
a
t
a
o
y
a
a
m
r
t
f
t
[
s
a
t
F
D
o
o
fR.C. Alver et al. / DNA
ut for metazoans with much larger genome sizes than yeasts, the
odel predicts that double fork stalls become highly likely and
ight be expected to occur in ∼50% of all S phases in a typical
uman somatic cell.
Chromosome fragile sites in metazoan cells may  represent a
imilar challenge to the large inter-origin gaps studied in yeasts.
ragile sites are chromosomal regions where there is a high fre-
uency of chromosomal breaks and rearrangements due to failures
n the process of DNA replication. The resulting DNA breaks at these
ites may  play an important role in tumourigenesis [20,60,79]. DNA
bre analysis of replication at fragile sites revealed paucity of active
eplication origins in these regions [20]. Replication defects at frag-
le sites may  be a consequence of a low density of licensed origins
r it may  reﬂect inefﬁcient or delayed initiation of replication forks.
. Regulation of dormant origins
Not all licensed origins actually ﬁre during a given S phase, but
nstead remain dormant and are passively replicated by forks ema-
ating from ﬂanking origins. When replication fork progression is
nhibited, for example as a consequence of reduced dNTP supply or
ue to forks encountering DNA damage, some origins which oth-
rwise would have remained dormant are activated. Under normal
unstressed) conditions, MCM  levels can be reduced approximately
 to 10-fold without any clear effect on the kinetics of S phase
rogression or the distribution of active origins. However, when
xposed to replicative stresses, cells with lowered MCM  levels have
 reduced number of dormant origins, leading to a reduced replica-
ion rate, greater signs of DNA damage and checkpoint activation,
nd decreased levels of cell survival [11,30,40,82].
Dormant origins must be regulated in such a way that they are
nly active when needed, but how is this achieved? DNA ﬁbre anal-
sis of replication in metazoans shows that ‘clusters’ of 2 to 10
djacent replication origins, each spanning a region of 0.5–1 Mbp,
re activated near synchronously in S phase. In addition, experi-
ents utilizing light microscopy have established that most DNA
eplication occurs in discrete ‘foci’ or ‘factories’, sub-nuclear struc-
ures which are enriched for active replication proteins [32]. Each
actory is estimated to contain 4–20 replication forks and is likely
o contain replication forks initiated from a single cluster of origins
32]. Different regions of the genome are replicated at different
tages of S phase and in a predictable, evolutionarily conserved
nd cell type speciﬁc manner [64,66]; this deﬁnes the replication-
iming program. However, which particular origins actually ﬁre in
Normal
early firing cluster 
     of origins
later firing cluster 
     of origins
ig. 3. Model for how cells respond to low levels of replicative stress. Two  adjacent clus
NA  (black lines). Under normal circumstances (left), the upper factory is activated slight
f  replicative stress (right), replication forks are inhibited in the earlier replicating cluster,
rigin ﬁring. Replicative stress activates DNA damage checkpoint kinases, which preferen
rom  [29].r 19 (2014) 182–189 185
a given cell cycle and which origins remain dormant appears to be
stochastic [1,21,31,47,65]. This observed stochasticity could be due
to the intrinsic inefﬁciency of origin ﬁring which itself may  be a
mechanism for regulating dormant origins. Because fork slowing
reduces the rate at which dormant origins are passively replicated
by adjacent origins, the probability of a dormant origin becoming
active increases when replication forks slow [10]. In this way, dor-
mant origin activation occurring in response to fork stalling is a
simple consequence of origin activation being stochastic. This sim-
ple system obviates the need for additional regulatory pathways
to activate dormant origins when the cell undergoes replication
stress. However it is also likely that dormant origins are, at least in
part, regulated by active mechanisms.
The protection against double-fork stalling that is achieved by
increasing the total number of licensed origins does not depend
on whether these origins are efﬁcient or whether they normally
remain dormant [10]. When cells are forced to ﬁre an excessive
number of replication origins, the demand for replication factors
increases dramatically, and it is potentially disastrous to initiate
replication using a replisome missing critical components that
have become limiting. Indeed, it has been observed that unre-
strained origin ﬁring causes exhaustion of the pool of RPA, which
in turn causes exposure of single stranded DNA and subsequent
DNA strand breakage [77]. Therefore, it is necessary to direct dor-
mant origin ﬁring speciﬁcally in the vicinity of the replication stress
(locally) whilst inhibiting origin ﬁring where replication has not
yet initiated (globally). Two key factors have been identiﬁed that
mediate this speciﬁc effect: the checkpoint kinase ATR and its
downstream effector kinase Chk1.
When cells are challenged with replication stress, single
stranded DNA coated with RPA becomes exposed due to a decou-
pling of the helicase and polymerase activities at the replication
fork: this is the substrate for ATR recruitment and activation, which
subsequently activates Chk1 kinase. ATR and Chk1 are known to
globally inhibit the rate of replication initiation. At low levels of
activity however, Chk1 preferentially inhibits the activation of new
replication factories rather than the initiation of dormant origins
within currently active factories [29]. The mechanism by which this
happens is unclear, but one possibility is that ATR and Chk1 mod-
estly reduce S phase Cdk levels, which has been shown to reduce
the level of active replication factories [76]. At the same time, the
slowing of replication forks within active factories stimulates dor-
mant origin ﬁring, either by the ‘passive’ mechanism described
above, or possibly by some other active mechanism. Active ATR is
Replication Inhibition
ATR/Chk1
inhibition of new 
factory/cluster
 activation
activation of 
dormant origins
ters of origins (factories bounded by green circles) are shown on a single piece of
ly earlier than the factory below, and each initiates three origins. Under low levels
 which promotes the ﬁring of dormant origins as a direct consequence of stochastic
tially inhibit the activation of the unﬁred later clusters/new factories. Reproduced
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xpected to be enriched at stalled or slowed replication forks, and
ould be in a good position to stimulate initiation of nearby unﬁred
rigins. Although ATR is known to phosphorylate the MCM2–7 pro-
eins [19], there is currently no direct evidence that this promotes
nitiation.
These two responses to replication fork inhibition – local activa-
ion of dormant origins and global suppression of factory activation
 work together to direct new initiation events towards regions of
he genome currently experiencing replicative problems whilst at
he same time limiting overall origin activation which otherwise
ight lead to depletion of key proteins such as RPA [11,29,77]. This
ombined response minimizes the deleterious consequences of
ork stalling and prevents similar problems from arising in unrepli-
ated regions of the genome (Fig. 3).
. The consequences of limited licensing
Recent studies have determined the biochemical, cellular and
henotypic consequences of limited licensing in mice and human
ystems. Fig. 4 outlines the different consequences of limiting MCM
ontent (right) or of limiting other pre-RC proteins (ORC/CDC6; left)
n either whole animals (coloured lines) or in vitro experiments
black lines). The consequences of limiting cellular MCM  content
n whole organisms are, in general, consistent with in vitro work,
howing evidence of increased DNA damage and genome insta-
ility. However, the situation appears more complex when other
re-RC components become limiting. In particular, the human
enetic disorder Meier–Gorlin syndrome (MGS), associated with
efective non-MCM pre-RC proteins is characterized by a number
f unexpected developmental defects.
In mice harbouring the hypomorphic allele MCM4Chaos3/Chaos3,
he mutant MCM4  protein is destabilized and only approximately
alf the wild type levels of functional MCM2–7 heterohexamers are
ig. 4. The consequences of limited licensing. Mutations of pre-RC components have
een organized into two groups, MCMs,  and non-MCMs (blue rectangles). The bio-
hemical consequences for these mutations are then organized into three groups:
CM  loading, decreased licensing activity, and ‘other’ (green rectangles). In turn,
hese biochemical defects lead to more general cellular defects, decreased prolif-
ration and genome instability (orange rectangles). Subsequently, these cellular
efects manifest as a phenotype observed at the organismal level (red rectangles).
he  arrows drawn from mutation to biochemical defect, to cellular defect, to pheno-
ype are colour coded in reference to the type of experimental system in which the
bservations have been made (red: mouse models harbouring MCM  hypomorphic
lleles; green: Meier Gorlin patients; blue: human MCM4  patients; black: in vitro
xperimental systems). Lines are dashed where assumptions are made in line with
bservations, but it is unclear if a direct cause and consequence can be conclusively
rawn.r 19 (2014) 182–189
loaded onto DNA [43,68]. This reduction limits the number of dor-
mant origins that are activated in response to replicative stresses
and results in genome instability. These cellular defects are not
strictly dependent on the individual hypomorphic MCM  allele used,
as a mouse model utilizing an MCM2IRES-CreERT2/IRES-CreERT2 allele,
which resulted in a reduction in total protein level to roughly 1/3
the wild type amount, exhibited similar defects in dormant origin
usage and genome instability [45,62]. A third hypomorphic allele,
MCM4  D573H, acts in a dominant way to make a non-functional
helicase whilst not affecting the stability of the mutant protein
itself [3]. Cells bearing any of these three mutations show evidence
of increased DNA damage and have unstable genomes. Consistent
with their observed genome instability, these mouse models are
highly cancer prone. In addition, there is some evidence that MCM
hypomorphic mice have severe deﬁciencies in the proliferative cell
compartments of a variety of tissues, potentially due to a depletion
of stem cells [62].
A set of human patients that present with natural killer cell
deﬁciency, growth retardation, adrenal insufﬁciency, and genome
instability were recently shown to harbour a mutation resulting
in expression of a truncated form of MCM4  [15,34,38]. Though
this truncated form does not seem to affect loading of the heli-
case onto DNA, cells from these patients exhibit increased levels
of chromosome breakage as well as a defective cell cycle. Human
tissue culture experiments in U2OS and HeLa cell lines utilizing
siRNA mediated knockdown of individual MCM  subunits corrob-
orate the biochemical and cellular defects observed in the mouse
models [30,40]. These data combined with the results from similar
experiments in Danio rerio [67], S. pombe [48], and C. elegans [82] all
lead to the conclusion that there is a threshold number of properly
functioning, licensed origins that needs to be maintained in order to
protect the cell from chromosomal instability and carcinogenesis.
Because of the inherent risk of trying to replicate the genome
with too few licensed origins, it would make sense if cells had a way
to ensure that a sufﬁcient number of origins have been licensed in
late G1 before the licensing system is shut down in preparation for
entry into S phase. Consistent with this idea, it has been shown that
certain metazoan cell lines possess a “licensing checkpoint” that
prevents G1 cells from entering S phase before the licensing system
is inhibited [49,51,56,69,74]. This checkpoint arrests cells in late G1
prior to full Cdk activation and consequent phosphorylation of the
retinoblastoma protein Rb, at a cell cycle stage where further origin
licensing should be possible. The precise molecular pathway under-
pinning the licensing checkpoint is currently unclear, but appears
to involve p53 and converges on down-regulating G1/S Cdk2 activ-
ity. The licensing checkpoint is defective in many cancer cell lines,
possibly because of its dependency on the p53-Rb control system
[49,56,69]. When licensing is inhibited in cells that do not have
a robust licensing checkpoint, cells progress into an S phase they
cannot complete, activate a DNA damage response and ultimately
die.
Another cellular defect that has been observed in mouse MCM
hypomorphs is an overall decrease in cellular proliferation, possi-
bly associated with a depletion of stem cell populations [45,62]. It is
difﬁcult to discern precisely why the proliferation rate is decreased
in these experiments: these cells all exhibit genome instability,
which means that the DNA damage response will be engaged and is
expected to slow cell cycle progression. Additionally, if the licensing
checkpoint is activated this would delay progression into S phase
and inhibit cellular proliferation.
In contrast to the phenotype of MCM  hypomorphic mice, human
patients with Meier Gorlin syndrome (MGS), a rare disorder linked
to defective non-MCM pre-RC proteins (ORC1, ORC4, ORC6, CDT1,
and CDC6) is characterized by primordial dwarﬁsm, mild to severe
microcephaly, and hypoplasia of the ear and patella [6,7,35]. Some
of these defects have been suggested to result from cell-type
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peciﬁc proliferation defects during development. The mutations
ound in MGS  patients result in a spectrum of biochemical and
ellular phenotypes that partially overlap with the effect of MCM
utations, including impaired licensing, altered S phase progres-
ion and proliferation defects. Notably absent from this list of
henotypes is chromosomal instability or an increased predispo-
ition to cancer. It is possible that in most cell types, the degree
f licensing inhibition in MGS  patients is slight enough to pre-
ominantly impact on development via activation of the licensing
heckpoint, resulting in a reduced number of cells in certain key
ell types such as neurons. However, at least under certain condi-
ions, MGS  mutations can cause fairly signiﬁcant reduction in origin
icensing [7,8]. It is also possible that some MGS  individuals might
ave an increased risk of cancer, but because MGS  is such a rare
isorder this has not become apparent in the clinical record.
Another possible explanation for the difference between the
henotype of MGS  and MCM  hypomorphs is that it stems from
unctions of the pre-RC proteins beyond their canonical role in
rigin licensing. A large number of studies have shown that non-
CM  pre-RC proteins are involved in mitotic events independent
f their role in origin licensing. The moonlighting of pre-RC pro-
eins in mitotic functions may  reﬂect a closer connection between
eplication origins and chromosome segregation in the ancestral
ukaryotic cell. ORC1, the largest ORC subunit is important for
he regulation of centrosome duplication [36,46], whilst the small-
st ORC subunit ORC6 has a role in cytokinesis [4,17,61]. ORC1
utations found in MGS  patient cells promote centrosome redu-
lication, most likely by affecting the ability of ORC1 to restrain
entrosome duplication via inhibition of Cyclin E-CDK2 kinase [37].
imilarly, CDT1 promotes microtubule attachment to kinetochores
80], whilst the CDT1 inhibitor, geminin, is involved in preventing
entrosome over-duplication [73]. In addition, cilia develop from
entrosomes/centrioles and ORC1, ORC4, ORC6, CDC6, and CDT1
ave all been implicated in cilia formation [71]. Given that several
ignalling pathways, such as Hedgehog signalling, depend on cilia,
his provides another route by which MGS  mutations could reduce
ellular proliferation rates without contributing to genetic instabil-
ty. CDC6 also has a non-licensing role in regulating the checkpoint
inase, ATR [18,55,59]. This may  be relevant to the MGS pheno-
ype as ATR mutations are implicated in Seckel syndrome, which
as several overlapping features with MGS, including microcephaly
71].
. Future perspectives
The organismal phenotypes of mutations in different pre-RC
omponents seem to reﬂect different contributions of their licens-
ng and non-licensing roles. The MCM  proteins predominantly
unction in DNA replication, and mutants therefore have conse-
uences resulting in defective proliferation, genome instability
nd cancer. The other pre-RC proteins have a range of addi-
ional functions, primarily centred around the centrosome, which
an inhibit cellular proliferation without signiﬁcantly promoting
enetic instability. Additional signalling defects mediated by defec-
ive formation of cilia may  also play a role. These additional roles
ould explain some of the more unexpected features of MGS  (Fig. 4).
MGS  therefore potentially provides an instructive disease for
nderstanding how mutations in proteins with promiscuous roles
an generate complex phenotypes. One way this can be exploited
s to distinguish mutations that cause a phenotype by generally
owering protein function (as appears to be the case with the
CM4-Chaos and MCM2-IRES mutants) from mutations that might
electively affect one particular function (such as appears to be
he case with the ORC1 MGS  mutation). Deeper understanding of
ow MGS  mutations cause the disease phenotypes will illuminate
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how their respective genes function in the context of interlocking
regulatory systems.
The organismal phenotypes caused by mutations in the licensing
system also highlights our limited understanding of what happens
to cells when the DNA replication programme is compromised. It
is currently unclear what the threshold values are for the num-
ber of licensed origins that will trigger the ‘licensing checkpoint’
and whether this varies between cell types. Understanding this will
have implications for the development of novel anticancer targets
that target the initiation of DNA replication [12]. The prediction that
in somatic mammalian cells there is a high probability of the occur-
rence of double fork stalls suggests that these cells will have evolved
mechanisms for effectively dealing with the consequences. Some
novel mechanisms have been proposed that could deal with this
sort of problem [50,86] and it will be interesting to see how these
pathways are affected when the activity of the licensing system is
compromised.
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